Like THCV, CBDV differs only from CBDV by replacing a pentyl (5 carbon) with a propyl (3 carbon) side chain. Although CBDV research is still in its early stages, recent studies have shown that it may be very promising for applications in treating epilepsy. This is due to the effect on the TRPV1 receptors and the modulation of gene expression.
Did you enjoy reading this article and do you like to write yourself? We are always looking for people who share our passion for natural products, who can also translate this into great texts. And we have an interesting reward for this. View all information for writers.